Related Experiment Video
Updated: Mar 23, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Recent advances in amyotrophic lateral sclerosis
Nilo Riva1, Federica Agosta2, Christian Lunetta3
1Neuropathology Unit, INSPE and Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology, San Raffaele Scientific Institute, Via Olgettina 48, 20132, Milan, Italy. riva.nilo@hsr.it.
Amyotrophic lateral sclerosis (ALS) management focuses on symptom relief, but recent research advances understanding of its molecular causes. This offers hope for new diagnostic and therapeutic strategies for this progressive neurodegenerative disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Clinical Medicine
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure.
- Current ALS management relies on multidisciplinary symptomatic and palliative care.
- Understanding ALS pathogenesis remains critical for developing effective treatments.
Purpose of the Study:
- To review recent advancements in understanding ALS pathogenesis.
- To highlight studies improving clinical management of ALS.
- To explore novel diagnostic and therapeutic approaches for ALS.
Main Methods:
- Literature review of recent scientific studies on ALS.
- Analysis of research on molecular mechanisms of ALS.
- Synthesis of findings related to clinical management and pathogenesis.
Main Results:
- Significant progress in understanding the molecular basis of ALS.
- Identification of potential new diagnostic biomarkers.
- Emerging therapeutic targets for ALS treatment.
Conclusions:
- Recent research offers new hope for ALS treatment and diagnosis.
- Continued investigation into molecular mechanisms is crucial.
- Multidisciplinary care remains essential for ALS patients.
More Related Videos
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...